Calcium phosphate-based nanomedicine mediated CRISPR/Cas9 delivery for prostate cancer therapy.
Front Bioeng Biotechnol
; 10: 1078342, 2022.
Article
in En
| MEDLINE
| ID: mdl-36588949
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Bioeng Biotechnol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland